U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C29H31N7O
Molecular Weight 493.6027
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of IMATINIB

SMILES

CN1CCN(CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC(=CC=N4)C5=CC=CN=C5)=C(C)C=C3)CC1

InChI

InChIKey=KTUFNOKKBVMGRW-UHFFFAOYSA-N
InChI=1S/C29H31N7O/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34)

HIDE SMILES / InChI

Approval Year

Unknown
86413
Name Type Language
IMATINIB
EMA EPAR   INN   MI   VANDF   WHO-DD  
INN  
Official Name English
Imatinib [WHO-DD]
Common Name English
NSC-743414
Code English
GLAMOX
Brand Name English
NSC-759854
Code English
IMATINIB [VANDF]
Common Name English
IMATINIB [MI]
Common Name English
imatinib [INN]
Common Name English
BENZAMIDE, 4-((4-METHYL-1-PIPERAZINYL)METHYL)-N-(4-METHYL-3-((4-(3-PYRIDINYL)-2-PYRIMIDINYL)AMINOPHENYL)-
Common Name English
IMATINIB [EMA EPAR]
Common Name English
Classification Tree Code System Code
WHO-ATC L01XE01
Created by admin on Fri Dec 15 15:46:43 UTC 2023 , Edited by admin on Fri Dec 15 15:46:43 UTC 2023
EMA ASSESSMENT REPORTS IMANTINIB TEVA (AUTHORIZED: LEUKEMIA, , MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE)
Created by admin on Fri Dec 15 15:46:43 UTC 2023 , Edited by admin on Fri Dec 15 15:46:43 UTC 2023
FDA ORPHAN DRUG 787520
Created by admin on Fri Dec 15 15:46:43 UTC 2023 , Edited by admin on Fri Dec 15 15:46:43 UTC 2023
FDA ORPHAN DRUG 831721
Created by admin on Fri Dec 15 15:46:43 UTC 2023 , Edited by admin on Fri Dec 15 15:46:43 UTC 2023
LIVERTOX NBK547959
Created by admin on Fri Dec 15 15:46:43 UTC 2023 , Edited by admin on Fri Dec 15 15:46:43 UTC 2023
EU-Orphan Drug EU/3/14/1357
Created by admin on Fri Dec 15 15:46:43 UTC 2023 , Edited by admin on Fri Dec 15 15:46:43 UTC 2023
FDA ORPHAN DRUG 208905
Created by admin on Fri Dec 15 15:46:43 UTC 2023 , Edited by admin on Fri Dec 15 15:46:43 UTC 2023
NDF-RT N0000175076
Created by admin on Fri Dec 15 15:46:43 UTC 2023 , Edited by admin on Fri Dec 15 15:46:43 UTC 2023
NCI_THESAURUS C155700
Created by admin on Fri Dec 15 15:46:43 UTC 2023 , Edited by admin on Fri Dec 15 15:46:43 UTC 2023
FDA ORPHAN DRUG 303810
Created by admin on Fri Dec 15 15:46:43 UTC 2023 , Edited by admin on Fri Dec 15 15:46:43 UTC 2023
EMA ASSESSMENT REPORTS IMANTINIB ACTAVIS (AUTHORIZED: LEUKEMIA, , MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE)
Created by admin on Fri Dec 15 15:46:43 UTC 2023 , Edited by admin on Fri Dec 15 15:46:43 UTC 2023
EMA ASSESSMENT REPORTS GLIVEC (AUTHORIZED: GASTROINTESTINAL STROMAL TUMORS)
Created by admin on Fri Dec 15 15:46:43 UTC 2023 , Edited by admin on Fri Dec 15 15:46:43 UTC 2023
EMA ASSESSMENT REPORTS IMATINIB MEDAC (AUTHORIZED DERMATOFIBROSARCOMA)
Created by admin on Fri Dec 15 15:46:43 UTC 2023 , Edited by admin on Fri Dec 15 15:46:43 UTC 2023
FDA ORPHAN DRUG 140100
Created by admin on Fri Dec 15 15:46:43 UTC 2023 , Edited by admin on Fri Dec 15 15:46:43 UTC 2023
NDF-RT N0000175605
Created by admin on Fri Dec 15 15:46:43 UTC 2023 , Edited by admin on Fri Dec 15 15:46:43 UTC 2023
EMA ASSESSMENT REPORTS IMANTIB ACCORD (AUTHORIZED: DERMATOFIBROSARCOMA)
Created by admin on Fri Dec 15 15:46:43 UTC 2023 , Edited by admin on Fri Dec 15 15:46:43 UTC 2023
WHO-VATC QL01XE01
Created by admin on Fri Dec 15 15:46:43 UTC 2023 , Edited by admin on Fri Dec 15 15:46:43 UTC 2023
Code System Code Type Description
DRUG BANK
DB00619
Created by admin on Fri Dec 15 15:46:43 UTC 2023 , Edited by admin on Fri Dec 15 15:46:43 UTC 2023
PRIMARY
CHEBI
45783
Created by admin on Fri Dec 15 15:46:43 UTC 2023 , Edited by admin on Fri Dec 15 15:46:43 UTC 2023
PRIMARY
SMS_ID
100000091894
Created by admin on Fri Dec 15 15:46:43 UTC 2023 , Edited by admin on Fri Dec 15 15:46:43 UTC 2023
PRIMARY
PUBCHEM
5291
Created by admin on Fri Dec 15 15:46:43 UTC 2023 , Edited by admin on Fri Dec 15 15:46:43 UTC 2023
PRIMARY
MESH
C097613
Created by admin on Fri Dec 15 15:46:43 UTC 2023 , Edited by admin on Fri Dec 15 15:46:43 UTC 2023
PRIMARY
EVMPD
SUB25387
Created by admin on Fri Dec 15 15:46:43 UTC 2023 , Edited by admin on Fri Dec 15 15:46:43 UTC 2023
PRIMARY
LACTMED
Imatinib
Created by admin on Fri Dec 15 15:46:43 UTC 2023 , Edited by admin on Fri Dec 15 15:46:43 UTC 2023
PRIMARY
NSC
743414
Created by admin on Fri Dec 15 15:46:43 UTC 2023 , Edited by admin on Fri Dec 15 15:46:43 UTC 2023
PRIMARY
EPA CompTox
DTXSID3037125
Created by admin on Fri Dec 15 15:46:43 UTC 2023 , Edited by admin on Fri Dec 15 15:46:43 UTC 2023
PRIMARY
RXCUI
282388
Created by admin on Fri Dec 15 15:46:43 UTC 2023 , Edited by admin on Fri Dec 15 15:46:43 UTC 2023
PRIMARY RxNorm
WIKIPEDIA
IMATINIB
Created by admin on Fri Dec 15 15:46:43 UTC 2023 , Edited by admin on Fri Dec 15 15:46:43 UTC 2023
PRIMARY
INN
8031
Created by admin on Fri Dec 15 15:46:43 UTC 2023 , Edited by admin on Fri Dec 15 15:46:43 UTC 2023
PRIMARY
DAILYMED
BKJ8M8G5HI
Created by admin on Fri Dec 15 15:46:43 UTC 2023 , Edited by admin on Fri Dec 15 15:46:43 UTC 2023
PRIMARY
NCI_THESAURUS
C62035
Created by admin on Fri Dec 15 15:46:43 UTC 2023 , Edited by admin on Fri Dec 15 15:46:43 UTC 2023
PRIMARY
MERCK INDEX
m6213
Created by admin on Fri Dec 15 15:46:43 UTC 2023 , Edited by admin on Fri Dec 15 15:46:43 UTC 2023
PRIMARY Merck Index
IUPHAR
5687
Created by admin on Fri Dec 15 15:46:43 UTC 2023 , Edited by admin on Fri Dec 15 15:46:43 UTC 2023
PRIMARY
ChEMBL
CHEMBL941
Created by admin on Fri Dec 15 15:46:43 UTC 2023 , Edited by admin on Fri Dec 15 15:46:43 UTC 2023
PRIMARY
FDA UNII
BKJ8M8G5HI
Created by admin on Fri Dec 15 15:46:43 UTC 2023 , Edited by admin on Fri Dec 15 15:46:43 UTC 2023
PRIMARY
NSC
759854
Created by admin on Fri Dec 15 15:46:43 UTC 2023 , Edited by admin on Fri Dec 15 15:46:43 UTC 2023
PRIMARY
DRUG CENTRAL
1423
Created by admin on Fri Dec 15 15:46:43 UTC 2023 , Edited by admin on Fri Dec 15 15:46:43 UTC 2023
PRIMARY
CAS
152459-95-5
Created by admin on Fri Dec 15 15:46:43 UTC 2023 , Edited by admin on Fri Dec 15 15:46:43 UTC 2023
PRIMARY
ACTIVE MOIETY
Structure of IMATINIB
METABOLITE ACTIVE (PARENT)
Structure of CGP-74588
PRODRUG (METABOLITE ACTIVE)
Structure of IKT-001PRO
PRODRUG (METABOLITE ACTIVE)
Structure of IKT-001PRO CATION
SALT/SOLVATE (PARENT)
Structure of Imatinib Mesylate
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966